Vitamin B deficit in AD patients reduces methylation of the glycogen synthase kinase 3β gene (GSK3β) at the promoter region, which promotes the expression of this protein kinase that induces tau phosphorylation, NFT aggregation, loss of cytoskeleton integrity, and cell death [87]. The gene discussed is MAPT; the disease is Alzheimer disease.